SE393980B - Forfarande for framstellning av 5-(och7-) bensoylindolin-2-oner med terapeutisk verkan - Google Patents
Forfarande for framstellning av 5-(och7-) bensoylindolin-2-oner med terapeutisk verkanInfo
- Publication number
- SE393980B SE393980B SE7306853A SE7306853A SE393980B SE 393980 B SE393980 B SE 393980B SE 7306853 A SE7306853 A SE 7306853A SE 7306853 A SE7306853 A SE 7306853A SE 393980 B SE393980 B SE 393980B
- Authority
- SE
- Sweden
- Prior art keywords
- benzoylindolin
- och7
- ones
- procedure
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B45/00—Complex metal compounds of azo dyes
- C09B45/02—Preparation from dyes containing in o-position a hydroxy group and in o'-position hydroxy, alkoxy, carboxyl, amino or keto groups
- C09B45/24—Disazo or polyazo compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B35/00—Disazo and polyazo dyes of the type A<-D->B prepared by diazotising and coupling
- C09B35/02—Disazo dyes
- C09B35/039—Disazo dyes characterised by the tetrazo component
- C09B35/08—Disazo dyes characterised by the tetrazo component the tetrazo component being a derivative of biphenyl
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Coloring (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25428472A | 1972-05-17 | 1972-05-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE393980B true SE393980B (sv) | 1977-05-31 |
Family
ID=22963675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7306853A SE393980B (sv) | 1972-05-17 | 1973-05-15 | Forfarande for framstellning av 5-(och7-) bensoylindolin-2-oner med terapeutisk verkan |
Country Status (17)
| Country | Link |
|---|---|
| JP (2) | JPS5139222B2 (fi) |
| AT (1) | AT323731B (fi) |
| BE (2) | BE799612A (fi) |
| CA (1) | CA1000715A (fi) |
| CH (1) | CH577469A5 (fi) |
| DE (2) | DE943075C (fi) |
| DK (1) | DK139677B (fi) |
| ES (1) | ES414802A1 (fi) |
| FI (1) | FI56377C (fi) |
| FR (1) | FR2184933B1 (fi) |
| GB (1) | GB1432577A (fi) |
| IE (1) | IE37641B1 (fi) |
| IL (1) | IL42216A (fi) |
| NL (2) | NL183187C (fi) |
| PH (1) | PH9815A (fi) |
| SE (1) | SE393980B (fi) |
| ZA (1) | ZA733151B (fi) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5371842U (fi) * | 1976-11-17 | 1978-06-15 | ||
| US4221716A (en) * | 1979-02-16 | 1980-09-09 | A. H. Robins Company, Inc. | Intermediate and process for the preparation of 7-acylindolin-2-ones |
| DE3300522A1 (de) * | 1982-01-21 | 1983-07-28 | Sandoz-Patent-GmbH, 7850 Lörrach | 3,3-dialkyl- und 3,3-alkylen-indolinderivate, verfahren zu ihrer herstellung und pharmazeutische praeparate sie enthaltend |
| JPH0349563Y2 (fi) * | 1985-08-31 | 1991-10-23 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH232507A (de) * | 1941-02-18 | 1944-05-31 | Chem Ind Basel | Verfahren zur Herstellung eines Disazofarbstoffes. |
-
0
- NL NL90149D patent/NL90149C/xx active
- BE BE524637D patent/BE524637A/xx unknown
-
1953
- 1953-11-25 DE DEC8502A patent/DE943075C/de not_active Expired
-
1973
- 1973-05-07 FI FI1452/73A patent/FI56377C/fi active
- 1973-05-08 IL IL42216A patent/IL42216A/en unknown
- 1973-05-09 ZA ZA733151A patent/ZA733151B/xx unknown
- 1973-05-11 DK DK263073AA patent/DK139677B/da unknown
- 1973-05-11 PH PH14608A patent/PH9815A/en unknown
- 1973-05-15 CH CH689973A patent/CH577469A5/xx not_active IP Right Cessation
- 1973-05-15 SE SE7306853A patent/SE393980B/xx unknown
- 1973-05-16 DE DE2324767A patent/DE2324767C2/de not_active Expired
- 1973-05-16 FR FR7317755A patent/FR2184933B1/fr not_active Expired
- 1973-05-16 BE BE131181A patent/BE799612A/xx not_active IP Right Cessation
- 1973-05-16 GB GB2337473A patent/GB1432577A/en not_active Expired
- 1973-05-16 CA CA171,512A patent/CA1000715A/en not_active Expired
- 1973-05-16 ES ES414802A patent/ES414802A1/es not_active Expired
- 1973-05-16 NL NLAANVRAGE7306832,A patent/NL183187C/xx not_active IP Right Cessation
- 1973-05-16 AT AT429973A patent/AT323731B/de not_active IP Right Cessation
- 1973-05-17 JP JP48054204A patent/JPS5139222B2/ja not_active Expired
- 1973-05-17 IE IE785/73A patent/IE37641B1/xx unknown
-
1976
- 1976-05-13 JP JP51054786A patent/JPS5910660B2/ja not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DK139677C (fi) | 1979-09-10 |
| ES414802A1 (es) | 1976-02-01 |
| PH9815A (en) | 1976-03-26 |
| BE524637A (fi) | |
| JPS5910660B2 (ja) | 1984-03-10 |
| AT323731B (de) | 1975-07-25 |
| AU5584773A (en) | 1974-11-21 |
| NL183187C (nl) | 1988-08-16 |
| IL42216A (en) | 1976-08-31 |
| NL90149C (fi) | |
| FI56377B (fi) | 1979-09-28 |
| GB1432577A (en) | 1976-04-22 |
| JPS5217466A (en) | 1977-02-09 |
| CA1000715A (en) | 1976-11-30 |
| NL183187B (nl) | 1988-03-16 |
| DE2324767C2 (de) | 1985-07-25 |
| NL7306832A (fi) | 1973-11-20 |
| IL42216A0 (en) | 1973-07-30 |
| FI56377C (fi) | 1980-01-10 |
| DE943075C (de) | 1956-05-09 |
| FR2184933B1 (fi) | 1976-05-14 |
| FR2184933A1 (fi) | 1973-12-28 |
| DE2324767A1 (de) | 1973-11-29 |
| DK139677B (da) | 1979-03-26 |
| JPS4941366A (fi) | 1974-04-18 |
| BE799612A (fr) | 1973-09-17 |
| IE37641L (en) | 1973-11-17 |
| ZA733151B (en) | 1974-04-24 |
| JPS5139222B2 (fi) | 1976-10-26 |
| CH577469A5 (fi) | 1976-07-15 |
| IE37641B1 (en) | 1977-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE417205B (sv) | Forfarande for framstellning av foreningar med autibiotisk verkan | |
| SE407579B (sv) | Forfarande for framstellning av n-fosfonometylglycin | |
| SE405599B (sv) | Forfarande for framstellning av pyridazinoner med terapeutisk verkan | |
| NO140731C (no) | Fremgangsmaate for fremstilling av dimetyleter | |
| SE395149B (sv) | Forfarande for framstellning av dibenso-tiepinylpiperazinderivat | |
| SE401676B (sv) | Forfarande for framstellning av dibensofuranderivat | |
| SE380522B (sv) | Forfarande for framstellning av (1- (p-klorbensoyl)-5-metoxi-2-metyl-3-indol) - acetoxiettiksyra med antiflogistisk verkan | |
| SE382053B (sv) | Forfarande for framstellning av bifenylylalkanoylaminopyridiner | |
| NO137899C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n (1h-tetrazol-5-yl)-kinaldamider | |
| SE389671B (sv) | Fforfarande for framstellning av 5-aroyl-pyrrolderivat med terapeutisk spec antiinflammatorisk verkan | |
| SE383151B (sv) | Forfarande for framstellning av 1-hydroxi-2-pyridoner | |
| SE395892B (sv) | Forfarande for framstellning av piperidyl-bensimidazoliner med terapeutisk verkan | |
| SE405851B (sv) | Forfarande for framstellning av nya 2-aminometylenindanoner med analgetisk verkan | |
| SE397827B (sv) | Forfarande for framstellning av 1-aminometyl-2,2-difenylcyklopropankarboxamidderivat med terapeutisk verkan | |
| SE392722B (sv) | Forfarande for framstellning av oxazolidinderivat med terapeutisk verkan | |
| SE7514308L (sv) | Forfarande for framstellning av tyrosinderivat med terapeutisk verkan | |
| SE380272B (sv) | Forfarande for framstellning av n-fosfonmetylglycin | |
| SE410732B (sv) | Analogiforfarande for framstellning av anilidderivat med terapeutisk verkan | |
| FI56830B (fi) | Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider | |
| SE415355B (sv) | Forfarande for framstellning av fosfonotioureider | |
| SE393980B (sv) | Forfarande for framstellning av 5-(och7-) bensoylindolin-2-oner med terapeutisk verkan | |
| SE385696B (sv) | Nytt forfarande for framstellning av n-(1-etyl-alfa-pyrrolidylmetyl)-2-metoxi-5-sulfamidobensamid med terapeutiska egenskaper | |
| SE7507887L (sv) | Forfarande for framstellning av bensopyranforeningar med terapeutisk verkan. | |
| SE380805B (sv) | Forfarande for framstellning av oxazoler | |
| SE394429B (sv) | Forfarande for framstellning av aminopyrrolderivat med terapeutisk verkan |